A detailed history of Mackenzie Financial Corp transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Mackenzie Financial Corp holds 9,484 shares of DGX stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,484
Previous 10,145 6.52%
Holding current value
$1.3 Million
Previous $1.39 Million 6.34%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$137.09 - $137.09 $90,616 - $90,616
-661 Reduced 6.52%
9,484 $1.3 Million
Q2 2024

Aug 14, 2024

SELL
$125.91 - $144.34 $1.11 Million - $1.27 Million
-8,826 Reduced 46.52%
10,145 $1.39 Million
Q1 2024

May 10, 2024

BUY
$123.78 - $142.11 $103,975 - $119,372
840 Added 4.63%
18,971 $2.53 Million
Q4 2023

Jan 30, 2024

SELL
$120.62 - $141.12 $2.17 Million - $2.53 Million
-17,962 Reduced 49.77%
18,131 $2.5 Million
Q3 2023

Oct 25, 2023

BUY
$121.86 - $144.92 $2.33 Million - $2.77 Million
19,142 Added 112.93%
36,093 $4.4 Million
Q2 2023

Aug 03, 2023

SELL
$130.56 - $146.84 $530,856 - $597,051
-4,066 Reduced 19.35%
16,951 $2.38 Million
Q1 2023

Apr 24, 2023

SELL
$131.53 - $155.76 $292,917 - $346,877
-2,227 Reduced 9.58%
21,017 $2.97 Million
Q4 2022

Feb 14, 2023

SELL
$123.31 - $157.26 $3.58 Million - $4.57 Million
-29,055 Reduced 55.56%
23,244 $3.64 Million
Q3 2022

Oct 07, 2022

SELL
$121.77 - $141.1 $823,895 - $954,682
-6,766 Reduced 11.46%
52,299 $6.42 Million
Q2 2022

Aug 10, 2022

BUY
$127.07 - $145.39 $2.68 Million - $3.06 Million
21,079 Added 55.49%
59,065 $7.85 Million
Q1 2022

May 13, 2022

SELL
$129.09 - $164.35 $3.3 Million - $4.2 Million
-25,568 Reduced 40.23%
37,986 $5.2 Million
Q4 2021

Feb 14, 2022

BUY
$140.36 - $173.01 $59,372 - $73,183
423 Added 0.67%
63,554 $11 Million
Q3 2021

Nov 08, 2021

BUY
$132.95 - $158.0 $3.06 Million - $3.64 Million
23,050 Added 57.51%
63,131 $9.17 Million
Q2 2021

Aug 11, 2021

SELL
$126.66 - $141.48 $2.49 Million - $2.78 Million
-19,651 Reduced 32.9%
40,081 $5.29 Million
Q1 2021

May 14, 2021

BUY
$114.63 - $133.34 $4.66 Million - $5.42 Million
40,652 Added 213.06%
59,732 $7.67 Million
Q4 2020

Feb 10, 2021

SELL
$112.7 - $128.05 $560,119 - $636,408
-4,970 Reduced 20.67%
19,080 $2.27 Million
Q3 2020

Nov 13, 2020

BUY
$107.05 - $130.01 $1.04 Million - $1.26 Million
9,716 Added 67.78%
24,050 $2.75 Million
Q2 2020

Aug 13, 2020

BUY
$73.34 - $122.61 $779,750 - $1.3 Million
10,632 Added 287.2%
14,334 $1.63 Million
Q1 2020

May 14, 2020

BUY
$75.14 - $115.68 $29,379 - $45,230
391 Added 11.81%
3,702 $297,000
Q4 2019

Feb 13, 2020

BUY
$100.29 - $107.99 $134,488 - $144,814
1,341 Added 68.07%
3,311 $354,000
Q3 2019

Nov 14, 2019

SELL
$97.85 - $107.42 $1,076 - $1,181
-11 Reduced 0.56%
1,970 $211,000
Q2 2019

Aug 14, 2019

SELL
$85.18 - $101.94 $30,068 - $35,984
-353 Reduced 15.12%
1,981 $202,000
Q1 2019

May 15, 2019

SELL
$80.68 - $89.92 $4.24 Million - $4.73 Million
-52,594 Reduced 95.75%
2,334 $210,000
Q4 2018

Feb 06, 2019

SELL
$79.75 - $108.38 $1.51 Million - $2.05 Million
-18,873 Reduced 25.57%
54,928 $4.57 Million
Q3 2018

Nov 15, 2018

BUY
$105.42 - $114.99 $647,700 - $706,498
6,144 Added 9.08%
73,801 $7.96 Million
Q2 2018

Aug 13, 2018

SELL
$97.35 - $113.14 $10.3 Million - $12 Million
-106,115 Reduced 61.07%
67,657 $7.44 Million
Q1 2018

May 14, 2018

SELL
$96.42 - $107.88 $8.12 Million - $9.09 Million
-84,233 Reduced 32.65%
173,772 $17.4 Million
Q4 2017

Feb 13, 2018

BUY
$90.86 - $100.24 $5.68 Million - $6.27 Million
62,505 Added 31.97%
258,005 $25.4 Million
Q3 2017

Nov 13, 2017

BUY
$91.96 - $108.35 $3.69 Million - $4.35 Million
40,164 Added 25.86%
195,500 $18.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
155,336
155,336 $17.3 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.